Pathways to Precision: Guideline for Programmed Death Ligand-1 and Tumor Mutation Burden Testing to Support the Selection of Immune Checkpoint Therapies in Lung Cancer.

Autor:	Cecchini MJ; From the Department of Pathology and Laboratory Medicine, London Health Sciences Centre, University Hospital, London, Ontario, Canada.
Jazyk:	angličtina
Zdroj:	Archives of pathology & laboratory medicine [Arch Pathol Lab Med] 2024 Jul 01; Vol. 148 (7), pp. 754-756.
DOI:	10.5858/arpa.2024-0141-ED
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF